The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
87558643 8755864 3 F 200410 20160728 20120827 20160802 EXP US-009507513-1204USA04555 MERCK 0.00 F Y 95.71000 KG 20160802 MD US US

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
87558643 8755864 1 PS FOSAMAX ALENDRONATE SODIUM 1 Oral 70 MG, UNK U 20560 70 MG TABLET
87558643 8755864 2 SS FOSAMAX ALENDRONATE SODIUM 1 Oral 35 MG, UNK U 20560 35 MG TABLET
87558643 8755864 3 C PRILOSEC OMEPRAZOLE MAGNESIUM 1 TO PRESENT 0 20 MG CAPSULE QD
87558643 8755864 4 C METICORTEN PREDNISONE 1 TO PRESENT U 0 5 MG TABLET QD
87558643 8755864 5 C AMLODIPINE AMLODIPINE BESYLATE 1 Oral TO PRESENT U 0 5 MG TABLET QD
87558643 8755864 6 C SIMVASTATIN. SIMVASTATIN 1 Oral TO PRESENT U 0 5 MG TABLET QD
87558643 8755864 7 C LOSARTAN POTASSIUM TABLETS LOSARTAN POTASSIUM 1 Oral TO PRESENT U 0 POWDER
87558643 8755864 8 SS FOSAMAX ALENDRONATE SODIUM 1 Oral U 20560 TABLET
87558643 8755864 9 SS FOSAMAX ALENDRONATE SODIUM 1 Oral 35 MG, QW U 20560 35 MG TABLET /wk
87558643 8755864 10 C BENICAR OLMESARTAN MEDOXOMIL 1 20 MG, QD 0 20 MG TABLET QD
87558643 8755864 11 C PREDNISONE. PREDNISONE 1 U 0

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
87558643 8755864 1 Lung transplant
87558643 8755864 4 Immunosuppression
87558643 8755864 5 Hypertension
87558643 8755864 6 Hyperlipidaemia
87558643 8755864 7 Hypertension
87558643 8755864 8 Osteoporosis
87558643 8755864 11 Lung transplant

Outcome of event

Event ID CASEID OUTC COD
87558643 8755864 OT
87558643 8755864 HO

Reactions reported

Event ID CASEID DRUG REC ACT PT
87558643 8755864 Acrochordon
87558643 8755864 Acute kidney injury
87558643 8755864 Breath sounds abnormal
87558643 8755864 Bursitis
87558643 8755864 Cardiac murmur
87558643 8755864 Chronic kidney disease
87558643 8755864 Complications of transplanted lung
87558643 8755864 Cough
87558643 8755864 Decreased appetite
87558643 8755864 Dehydration
87558643 8755864 Depression
87558643 8755864 Diarrhoea
87558643 8755864 Drug level above therapeutic
87558643 8755864 Femur fracture
87558643 8755864 Gastrooesophageal reflux disease
87558643 8755864 Headache
87558643 8755864 Impaired healing
87558643 8755864 Insomnia
87558643 8755864 Intramedullary rod insertion
87558643 8755864 Mammogram abnormal
87558643 8755864 Nausea
87558643 8755864 Off label use
87558643 8755864 Pain in jaw
87558643 8755864 Pathological fracture
87558643 8755864 Pleural effusion
87558643 8755864 Pneumonia
87558643 8755864 Pulmonary fibrosis
87558643 8755864 Renal failure
87558643 8755864 Restless legs syndrome
87558643 8755864 Sinusitis
87558643 8755864 Somnolence
87558643 8755864 Stress fracture
87558643 8755864 Thyroid disorder

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
87558643 8755864 1 200410 0
87558643 8755864 2 200801 0
87558643 8755864 3 200407 0
87558643 8755864 4 200407 0
87558643 8755864 5 200407 0
87558643 8755864 6 200407 0
87558643 8755864 7 200407 0
87558643 8755864 10 200407 0